NCT05960461 Families Moving Forward (FMF) Connect Pro for Mental Health Providers
| NCT ID | NCT05960461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Fetal Alcohol Spectrum Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-03-22 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2024-03-22 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app. Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website. The main questions this study aims to answer are: * What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)? * Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change? All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.
Eligibility Criteria
Inclusion Criteria: * Licensed mental health provider or supervised trainee * Employed by a community mental agency or in private practice * provides mental health services to children ages 3 to 12 or their families * provides services in the United States * Fluency in English * Access to the internet Exclusion Criteria: * Provides services outside of the United States * Does not provide mental health services to children ages 3 to 12
Frequently Asked Questions
Who can join the NCT05960461 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fetal Alcohol Spectrum Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05960461 currently recruiting?
Yes, NCT05960461 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Rochester to inquire about joining.
Where is the NCT05960461 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05960461 clinical trial?
NCT05960461 is sponsored by University of Rochester. The trial plans to enroll 250 participants.